CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 72 filers reported holding CULLINAN ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88,000 | -9.3% | 9,756 | +8.5% | 0.00% | – |
| Q2 2023 | $97,000 | +546.7% | 8,991 | +499.8% | 0.00% | – |
| Q1 2023 | $15,000 | -68.1% | 1,499 | -66.8% | 0.00% | – |
| Q4 2022 | $47,000 | +840.0% | 4,513 | +1097.1% | 0.00% | – |
| Q3 2022 | $5,000 | -28.6% | 377 | -34.4% | 0.00% | – |
| Q2 2022 | $7,000 | -75.9% | 575 | -79.1% | 0.00% | – |
| Q1 2022 | $29,000 | -71.3% | 2,747 | -57.9% | 0.00% | – |
| Q4 2021 | $101,000 | +57.8% | 6,528 | +132.3% | 0.00% | – |
| Q3 2021 | $64,000 | +178.3% | 2,810 | +209.8% | 0.00% | – |
| Q2 2021 | $23,000 | -55.8% | 907 | -27.9% | 0.00% | – |
| Q1 2021 | $52,000 | – | 1,258 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $78,241,782 | 20.33% |
| CHI Advisors LLC | 3,349,460 | $34,264,977 | 9.10% |
| Nextech Invest Ltd. | 1,221,145 | $12,492,313 | 5.21% |
| BVF INC/IL | 3,196,701 | $32,702,251 | 1.20% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 265,032 | $2,711,277 | 1.12% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $5,115,000 | 0.76% |
| Atom Investors LP | 120,109 | $1,228,715 | 0.67% |
| Boxer Capital, LLC | 1,074,082 | $10,988 | 0.54% |
| SVB FINANCIAL GROUP | 20,274 | $207,403 | 0.40% |
| Parkman Healthcare Partners LLC | 169,886 | $1,737,934 | 0.38% |